Skip to main content
The Globe and Mail
Support Quality Journalism
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
Just$1.99
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to globeandmail.com
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(select.open)}function setPanelState(o){dom.root.classList[o?"add":"remove"](select.open),dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); }

While pot-stock performance was mixed Monday, many of the bigger names fell: Canopy Growth Corp., Aurora, Cronos Group Inc., Tilray Inc., Hexo and Organigram Holdings Inc. all saw their shares decline.

Adrian Wyld/The Canadian Press

Pot investors continue to feel the pain of an awful 2019, as the pioneering cannabis exchange-traded fund, which once commanded more than $1-billion of investors’ money, fell to its lowest point ever.

The Horizons Marijuana Life Sciences Index ETF, known by its ticker symbol HMMJ, traded as low as $8.14 a unit and closed at $8.16 Monday. The prices represented all-time intra-day and closing lows since the fund’s April, 2017, debut. The fund’s unit price is down 66 per cent since March 19 and has been halved since the middle of August.

Canadian cannabis stocks have tumbled in 2019 as most companies have badly missed sales expectations in the sector’s troubled rollout. And the sector didn’t get a break from bad news over the holidays. Investors fled the shares of Aurora Cannabis Inc., with the stock down 15 per cent, after it revealed Dec. 21 the abrupt departure of chief corporate officer Cam Battley, its most visible executive. Hexo Corp. displeased investors by doing a U.S. equity financing, announced on the Boxing Day holiday on Dec. 26, at a steep discount to its market price. Its shares are down 22 per cent from their Christmas Eve close.

Story continues below advertisement

While pot-stock performance was mixed Monday, many of the bigger names fell: Canopy Growth Corp., Aurora, Cronos Group Inc., Tilray Inc., Hexo and Organigram Holdings Inc. all saw their shares decline.

As the market capitalization of pot companies shrivels, a number of smaller cannabis companies are getting dropped by the index-makers whose work determines which stocks are held by funds such as HMMJ.

In a group of 80 pot stocks that have been members of the Solactive North America Marijuana Index at one point in 2019, just 16 have posted positive returns for the year, according to S&P Global Market Intelligence. Thirty-eight of the 80 companies have lost at least half their value in 2019.

Horizons uses the Solactive index as the basis for HMMJ, but can make adjustments based on the stocks’ liquidity. Its Toronto Stock Exchange listing means it also doesn’t include shares of cannabis firms that do business in the United States, where the drug is illegal under federal law.

Recent changes by Solactive and Horizons underscore the damage to the sector. Solactive cut 12 stocks from its index, which requires a minimum market capitalization of $67.5-million, in its December reconstitution. The changes brought membership to 59.

Horizons said Monday that the Solactive changes drove it to drop seven stocks: Heritage Cannabis Holdings Corp.; Emerald Health Therapeutics Inc.; Eve & Co. Inc.; Fsd Pharma Inc.; 48North Cannabis Corp.; Radient Technologies Inc.; and Zenabis Global Inc.

HMMJ was the world’s first cannabis investment fund and the largest on the day Canada legalized the drug in October, 2018. A U.S.-based fund, ETFMG Alternative Harvest (MJ), has since passed HMMJ in size, but it has fared only slightly better, with year-to-date and six-month losses of nearly 30 per cent and 43 per cent, respectively.

Story continues below advertisement

In a statement accompanying the rebalancing, Horizons chief executive Steve Hawkins called the performance of the marijuana sector in the fourth quarter “quite disappointing,” but said the remaining stocks represent "the survival of the fittest: HMMJ’s holdings are now more concentrated on companies that are maintaining a strong position within the cannabis industry, despite difficult market conditions.” HMMJ’s assets were down to about $427-million as of Dec. 27.

Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies